{"version":"1.0","type":"link","title":"Brentuximab vedotin as monotherapy for unresectable breast implant-associated anaplastic large cell lymphoma.","author_name":"Stack A 외","author_url":"https://prs-insight.online/author/Stack%20A","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/74152","thumbnail_width":1200,"thumbnail_height":630}